Surgical approaches for infratemporal fossa tumor resection: Fifteen years' experience of a single center.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
11 2019
Historique:
received: 12 11 2018
revised: 01 06 2019
accepted: 19 07 2019
pubmed: 14 8 2019
medline: 21 11 2020
entrez: 14 8 2019
Statut: ppublish

Résumé

The aims of this study were to report our center's experience with infratemporal fossa (ITF) tumors, to review the treatment modalities and outcomes. Data of patients that underwent resection of ITF tumors in a single tertiary referral medical center were collected and analyzed. Sixty-three patients were included. Sarcoma was the most common pathology (18; 29%). The most common surgical approach was the preauricular-orbitozygomatic approach (24; 38%), followed by endoscopic, craniofacial resection, and combined approaches. Forty-seven patients (75%) required reconstruction, 23 (49%) involving free tissue transfer. Thirty-five patients (76%) with malignant lesions required adjuvant therapy consisting of radiotherapy, chemotherapy, or both. Thirty-three patients suffered from complications related to surgery or adjuvant therapy. The three- and five-years survival rates for malignancy were 82% and 66%, respectively. Complete surgical resection of ITF involving tumors is feasible, providing good long-term survival. Multidisciplinary approach is the key for success.

Sections du résumé

BACKGROUND
The aims of this study were to report our center's experience with infratemporal fossa (ITF) tumors, to review the treatment modalities and outcomes.
METHODS
Data of patients that underwent resection of ITF tumors in a single tertiary referral medical center were collected and analyzed.
RESULTS
Sixty-three patients were included. Sarcoma was the most common pathology (18; 29%). The most common surgical approach was the preauricular-orbitozygomatic approach (24; 38%), followed by endoscopic, craniofacial resection, and combined approaches. Forty-seven patients (75%) required reconstruction, 23 (49%) involving free tissue transfer. Thirty-five patients (76%) with malignant lesions required adjuvant therapy consisting of radiotherapy, chemotherapy, or both. Thirty-three patients suffered from complications related to surgery or adjuvant therapy. The three- and five-years survival rates for malignancy were 82% and 66%, respectively.
CONCLUSION
Complete surgical resection of ITF involving tumors is feasible, providing good long-term survival. Multidisciplinary approach is the key for success.

Identifiants

pubmed: 31407445
doi: 10.1002/hed.25906
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3755-3763

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Sekhar LN, Schramm VL Jr, Jones NF. Subtemporal-preauricular infratemporal fossa approach to large lateral and posterior cranial base neoplasms. J Neurosurg. 1987;67(4):488-499.
Barbosa JF. Surgery of extensive cancer of paranasal sinuses. Presentation of a new technique. Arch Otolaryngol. 1961;73:129-138.
Conley JJ. The surgical approach to the pterygoid area. Ann Surg. 1956;144(1):39-43.
Fisch U. The infratemporal fossa approach for nasopharyngeal tumors. Laryngoscope. 1983;93(1):36-44.
Janecka IP. Classification of facial translocation approach to the skull base. Otolaryngol Head Neck Surg. 1995;112(4):579-585.
Battaglia P, Turri-Zanoni M, Dallan I, et al. Endoscopic endonasal transpterygoid transmaxillary approach to the infratemporal and upper parapharyngeal tumors. Otolaryngol Head Neck Surg. 2014;150(4):696-702.
Bigelow DC, Smith PG, Leonetti JP, Backer RL, Grubb RL, Kotapka MJ. Treatment of malignant neoplasms of the lateral cranial base with the combined frontotemporal-anterolateral approach: five-year follow-up. Otolaryngol Head Neck Surg. 1999;120(1):17-24.
Givi B, Liu J, Bilsky M, et al. Outcome of resection of infratemporal fossa tumors. Head Neck. 2013;35(11):1567-1572.
Hentschel SJ, Vora Y, Suki D, Hanna EY, DeMonte F. Malignant tumors of the anterolateral skull base. Neurosurgery. 2010;66(1):102-112. discussion 112.
Iannetti G, Belli E, Cicconetti A, Delfini R, Ciappetta P. Infratemporal fossa surgery for malignant diseases. Acta Neurochir. 1996;138(6):658-671. discussion 671.
Smith PG, Grubb RL, Kletzker GR, Leonetti JP. Combined pterional-anterolateral approaches to cranial base tumors. Otolaryngol Head Neck Surg. 1990;103(3):357-363.
Timoshenko AP, Asanau A, Gavid M, Colin V, Martin C, Prades JM. Preauricular transmandibular and transzygomatic approach for tumors of the infratemporal fossa revisited. ORL J Otorhinolaryngol Relat Spec. 2013;75(4):250-255.
Taylor RJ, Patel MR, Wheless SA, et al. Endoscopic endonasal approaches to infratemporal fossa tumors: a classification system and case series. Laryngoscope. 2014;124(11):2443-2450.
Arnaoutakis D, Kadakia S, Abraham M, Lee T, Ducic Y. Locoregional and microvascular free tissue reconstruction of the lateral skull base. Semin Plast Surg. 2017;31(4):197-202.
Kwon D, Iloreta A, Miles B, Inman J. Open anterior skull base reconstruction: a contemporary review. Semin Plast Surg. 2017;31(4):189-196.
Duek I, Pener-Tessler A, Yanko-Arzi R, et al. Skull base reconstruction in the pediatric patient. J Neurol Surg B Skull Base. 2018;79(1):81-90.
Youssef A, Carrau RL, Tantawy A, et al. Endoscopic versus open approach to the infratemporal fossa: a cadaver study. J Neurol Surg B Skull Base. 2015;76(5):358-364.

Auteurs

Daniel Yafit (D)

Department of Otolaryngology, Head & Neck and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Irit Duek (I)

Department of Otolaryngology, Head & Neck and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Sara Abu-Ghanem (S)

Department of Otolaryngology, Head & Neck and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Omer J Ungar (OJ)

Department of Otolaryngology, Head & Neck and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Anat Wengier (A)

Department of Otolaryngology, Head & Neck and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Helena Moshe-Levyn (H)

Department of Otolaryngology, Head & Neck and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ravit Yanko-Arzi (R)

Department of Plastic and Reconstructive Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Arik Zaretski (A)

Department of Plastic and Reconstructive Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Nevo Margalit (N)

Department of Neurosurgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Avraham Abergel (A)

Department of Otolaryngology, Head & Neck and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Nidal Muhanna (N)

Department of Otolaryngology, Head & Neck and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Dan M Fliss (DM)

Department of Otolaryngology, Head & Neck and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH